-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DqjolID/pAMF21gRwSiiMTv4DTDS1O+zXUek1U1TU2YicnL8xWsp41ZTTa8W6U0d MVD/7oHSretDksPp9ivy7g== 0000732485-03-000068.txt : 20031204 0000732485-03-000068.hdr.sgml : 20031204 20031204161630 ACCESSION NUMBER: 0000732485-03-000068 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030630 FILED AS OF DATE: 20031204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TERMEER HENRI A CENTRAL INDEX KEY: 0001021038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 333-90510 FILM NUMBER: 031038215 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 ter96.xml X0201 4/A 2003-06-30 2003-07-02 0 0000732485 GENZYME CORP GENZ 0001021038 TERMEER HENRI A GENZYME CORPORATION ONE KENDALL SQUARE CAMBRIDGE MA 021391562 1 1 0 0 Chmn, President and CEO Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 383265 0 D 0 D Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 1783 0 D 0 I By 401(k) Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 2434 0 D 0 I By Spouse Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 2899 0 D 0 I By Trust Genzyme General common stock (GENZ) 2003-06-30 4 J 0 18910 0 A 584870 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 1261 0 A 586131 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 87 0 A 16424 I By 401(k) Genzyme General common stock (GENZ) 2003-06-30 4 J 0 119 0 A 2365 I By Spouse Genzyme General common stock (GENZ) 2003-06-30 4 J 0 6 0 A 2371 I By Spouse Genzyme General common stock (GENZ) 2003-06-30 4 J 0 142 0 A 1142 I By Trust Genzyme General common stock (GENZ) 2003-06-30 4 J 0 114 0 A 1256 I By Trust Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 22332 0 D 0 D Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 8 0 D 0 I By 401(k) Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 120 0 D 0 I By Spouse Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 2019 0 D 0 I By Trust Molecular Oncology NQ stock option (right to buy) 12.73 2003-06-30 4 J 0 150000 0 D 2000-05-25 2010-05-25 Genzyme Molecular Oncology common stock (GZMO) 150000 0 D Molecular Oncology NQ stock option (right to buy) 15.40 2003-06-30 4 J 0 100000 0 D 2001-05-31 2011-05-31 Genzyme Molecular Oncology common stock (GZMO) 100000 0 D Molecular Oncology NQ stock option (right to buy) 2.33 2003-06-30 4 J 0 125000 0 D 2002-05-30 2012-05-30 Genzyme Molecular Oncology common stock (GZMO) 125000 0 D Biosurgery NQ stock option (right to buy) 14.17 2003-06-30 4 J 0 22123 0 D 1994-12-16 2004-12-16 Genzyme Biosurgery common stock (GZBX) 22123 0 D Biosurgery NQ stock option (right to buy) 52.21 2003-06-30 4 J 0 18622 0 D 2005-06-30 2005-12-15 Genzyme Biosurgery common stock (GZBX) 18622 0 D Biosurgery NQ stock option (right to buy) 29.46 2003-06-30 4 J 0 17430 0 D 1997-10-16 2007-10-16 Genzyme Biosurgery common stock (GZBX) 17430 0 D Biosurgery NQ stock option (right to buy) 19.39 2003-06-30 4 J 0 10458 0 D 1998-05-28 2008-05-28 Genzyme Biosurgery common stock (GZBX) 10458 0 D Biosurgery NQ stock option (right to buy) 23.12 2003-06-30 4 J 0 24770 0 D 2001-01-25 2009-01-25 Genzyme Biosurgery common stock (GZBX) 24770 0 D Biosurgery NQ stock option (right to buy) 11.04 2003-06-30 4 J 0 95445 0 D 1999-08-26 2009-08-26 Genzyme Biosurgery common stock (GZBX) 95445 0 D Biosurgery NQ stock option (right to buy) 6.26 2003-06-30 4 J 0 100000 0 D 2001-05-31 2011-05-31 Genzyme Biosurgery common stock (GZBX) 100000 0 D Biosurgery NQ stock option (right to buy) 6.26 2003-06-30 4 J 0 150000 0 D 2008-05-31 2011-05-31 Genzyme Biosurgery common stock (GZBX) 150000 0 D Biosurgery NQ stock option (right to buy) 4.24 2003-06-30 4 J 0 125000 0 D 2002-05-30 2012-05-30 Genzyme Biosurgery common stock (GZBX) 125000 0 D Genzyme General NQ stock option (right to buy) 286.56 2003-06-30 4 J 0 1093 0 A 1994-12-16 2004-12-16 Genzyme General common stock (GENZ) 1093 1093 D Genzyme General NQ stock option (right to buy) 0.00 2003-06-30 4 J 0 920 0 A 2005-06-30 2005-12-15 Genzyme General common stock (GENZ) 920 920 D Genzyme General NQ stock option (right to buy) 595.76 2003-06-30 4 J 0 861 0 A 1997-10-16 2007-10-16 Genzyme General common stock (GENZ) 861 861 D Genzyme General NQ stock option (right to buy) 124.69 2003-06-30 4 J 0 3705 0 A 1997-10-16 2007-10-16 Genzyme General common stock (GENZ) 3705 3705 D Genzyme General NQ stock option (right to buy) 392.12 2003-06-30 4 J 0 517 0 A 1998-05-28 2008-05-28 Genzyme General common stock (GENZ) 517 517 D Genzyme General NQ stock option (right to buy) 124.69 2003-06-30 4 J 0 1751 0 A 1998-05-28 2008-05-28 Genzyme General common stock (GENZ) 1751 1751 D Genzyme General NQ stock option (right to buy) 467.55 2003-06-30 4 J 0 1224 0 A 2001-01-25 2009-01-25 Genzyme General common stock (GENZ) 1224 1224 D Genzyme General NQ stock option (right to buy) 95.84 2003-06-30 4 J 0 4148 0 A 2001-01-25 2009-01-25 Genzyme General common stock (GENZ) 4148 4148 D Genzyme General NQ stock option (right to buy) 223.26 2003-06-30 4 J 0 4719 0 A 1999-08-26 2009-08-26 Genzyme General common stock (GENZ) 4719 4719 D Genzyme General NQ stock option (right to buy) 226.76 2003-06-30 4 J 0 8421 0 A 2000-05-25 2010-05-25 Genzyme General common stock (GENZ) 8421 8421 D Genzyme General NQ stock option (right to buy) 126.60 2003-06-30 4 J 0 4945 0 A 2001-05-31 2011-05-31 Genzyme General common stock (GENZ) 4945 4945 D Genzyme General NQ stock option (right to buy) 274.32 2003-06-30 4 J 0 5614 0 A 2001-05-31 2011-05-31 Genzyme General common stock (GENZ) 5614 5614 D Genzyme General NQ stock option (right to buy) 126.60 2003-06-30 4 J 0 7417 0 A 2008-05-31 2011-05-31 Genzyme General common stock (GENZ) 7417 7417 D Genzyme General NQ stock option (right to buy) 85.75 2003-06-30 4 J 0 6181 0 A 2002-05-30 2012-05-30 Genzyme General common stock (GENZ) 6181 6181 D Genzyme General NQ stock option (right to buy) 41.51 2003-06-30 4 J 0 7017 0 A 2002-05-30 2012-05-30 Genzyme General common stock (GENZ) 7017 7017 D Molecular Oncology NQ stock option (right to buy) 7.00 2003-06-30 4 J 0 66000 0 D 1997-10-16 2007-10-16 Genzyme Molecular Oncology common stock (GZMO) 66000 0 D Molecular Oncology NQ stock option (right to buy) 7.00 2003-06-30 4 J 0 31200 0 D 1998-05-28 2008-05-28 Genzyme Molecular Oncology common stock (GZMO) 31200 0 D Molecular Oncology NQ stock option (right to buy) 5.38 2003-06-30 4 J 0 73899 0 D 2001-01-25 2009-01-25 Genzyme Molecular Oncology common stock (GZMO) 73899 0 D On June 30, 2003 all outstanding shares of Genzyme Biosurgery and Genzyme Molecular stock were exchanged for shares of Genzyme General Stock. Genzyme Biosurgery shareholders received .04914 of a share of Genzyme General stock for each Biosurgery share and Genzyme Molecular Oncology shareholders received .05653 of a share of Genzyme General stock for each Molecular Oncology share. On June 30, 2003 in relation to the elimination of Genzyme's tracking stock structure, all stock options of Genzyme Biosurgery and Genzyme Molecular were exchanged for stock options of Genzyme General. The exchange ratio was based on the closing prices of all three stocks on 6/30/03. Genzyme Biosurgery options were exchanged at a rate of .04945 and Genzyme Molecular Oncology options were exchanged at a rate of .05614. Options vest in 20% annual increments beginning 12/16/94. Options vest 20% on October 16, 1997 and in 20% annual increments beginning May 16, 1998. Options vest in 20% annual increments beginning on the original date of grant. Options were granted with an exercise price 100% above fair market value, and vest in 1/3 increments on each of Janary 25, 2001, 2002 and 2003. Options vest 20% on August 26, 1999 and in 20% annual increments beginning May 26, 2000. These options may be accelerated by the board if (1) in each of two consecutive calendar years the average annual Total Shareholder Return for the applicable Genzyme stock equals or exceeds the 75th percentile of the S&P Biotechnology Index (super), and (2) the share price for the applicable Genzyme stock has appreciated at a rate equal to or greater than a compounded annual rate of ten percent from the date of grant. These options have a converted exercise price of $1,055.82 per share. By: Susan P. Cogswell, Attorney-in-Fact 2003-12-04 -----END PRIVACY-ENHANCED MESSAGE-----